Status:
COMPLETED
QUANTRA® References Range Protocol in Pregnancy and Postpartum
Lead Sponsor:
University Hospital, Lille
Conditions:
Pregnancy Postpartum
Eligibility:
FEMALE
18+ years
Brief Summary
Postpartum hemorrhage (PPH) remains the leading cause of maternal death. PPH associated coagulopathy varies and their treatments (tranexamic acid, fibrinogen concentrates,plasma, platelets need to be ...
Eligibility Criteria
Inclusion
- Healthy pregnant woman (indemne of any chronic pathology neither obstetrical pathology)
- Delivering vaginally without postpartum hemorrhage for 60 patients
- Delivering through a programmed C-section for 20 patients
- Having given a non-opposition agreement to participate in the study.
- Major patient with social insurance
Exclusion
- Any acute or chronic hemostasis pathology before pregnancy or during pregnancy instrumental delivery or cesarean section Postpartum bleeding.
Key Trial Info
Start Date :
May 5 2021
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
November 7 2022
Estimated Enrollment :
31 Patients enrolled
Trial Details
Trial ID
NCT04753671
Start Date
May 5 2021
End Date
November 7 2022
Last Update
December 26 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hop Jeanne de Flandre Chu Lille
Lille, France, 59037